coronavirus disease 19 infectio VLP-based vaccine (Catalent/Spicona)

N/A

Report date: 2025/01/26 17:20:46

Base Information

Drug Namecoronavirus disease 19 infectio VLP-based vaccine (Catalent/Spicona)
Drug Alias NameSARS-CoV-2 Spike glycoprotein modulator (Catalent/Spicona)
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCatalent Inc
China Registration ClassN/A

Develop Information

Active CompaniesSpicona IncCatalent Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A